Kasia M. Dillon

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer

Z. Szallasi, K. Mouw, A. Choudhury, 2022, npj Precision Oncology.

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

Z. Szallasi, S. Brunak, I. Csabai, 2020, Clinical Cancer Research.